Guy-Charles Fanneau de la Horie
Directeur/Membre du Conseil chez GENFLOW BIOSCIENCES PLC
Fortune : 9 861 $ au 30/06/2024
Profil
Dr. Guy-Charles Fanneau de la Horie is an Independent Non-Executive Director at Genflow Biosciences Plc.
He is on the Board of Directors at Pharnext SA and Genflow Biosciences Plc.
Dr. Fanneau de la Horie was previously employed as a Chief Executive Officer by Pherecydes Pharma SA, a Chief Executive Officer & Director by Neovacs SA, and a Chief Executive Officer by PathoQuest SAS.
He also served on the board at Nanobiotix SA. He received his MBA from INSEAD.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GENFLOW BIOSCIENCES PLC
0,09% | 31/12/2022 | 300 000 ( 0,09% ) | 9 861 $ | 30/06/2024 |
Postes actifs de Guy-Charles Fanneau de la Horie
| Sociétés | Poste | Début |
|---|---|---|
| GENFLOW BIOSCIENCES PLC | Directeur/Membre du Conseil | 29/06/2022 |
| PHARNEXT SCA | Directeur/Membre du Conseil | 10/07/2023 |
Anciens postes connus de Guy-Charles Fanneau de la Horie
| Sociétés | Poste | Fin |
|---|---|---|
| PHERECYDES PHARMA | Directeur Général | 19/05/2022 |
| NEOVACS | Directeur Général | 17/10/2013 |
PathoQuest SAS
 PathoQuest SAS Medical SpecialtiesHealth Technology PathoQuest SAS provides diagnostic development services for cancer and infectious diseases. Its services include viral safety testing, adventitious virus detection in cell lines under development and in Master Cell Banks, adventitious virus detection in viral stocks, and identify of the sequences of murine sarcoma virus. The company was founded by Luc Boblet and Marc Eloit on September 14, 2010 and is headquartered in Paris, France. | Directeur Général | - |
| NANOBIOTIX | Directeur/Membre du Conseil | - |
Formation de Guy-Charles Fanneau de la Horie
| INSEAD | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| NEOVACS | Health Technology |
| NANOBIOTIX | Health Technology |
| GENFLOW BIOSCIENCES PLC | Health Technology |
| PHARNEXT SCA | Health Technology |
| Entreprise privées | 2 |
|---|---|
Pherecydes Pharma SA
 Pherecydes Pharma SA Pharmaceuticals: MajorHealth Technology Pherecydes Pharma SA is a biotechnology company, which engages in the research and development of anti-infective therapies based on the use of bacteriophages. It develops phage treatments of bacterial infections. The company was founded by Jerome Gabard and Manuel Gea in December 2006 and is headquartered in Romainville, France. | Health Technology |
PathoQuest SAS
PathoQuest SAS Medical SpecialtiesHealth Technology PathoQuest SAS provides diagnostic development services for cancer and infectious diseases. Its services include viral safety testing, adventitious virus detection in cell lines under development and in Master Cell Banks, adventitious virus detection in viral stocks, and identify of the sequences of murine sarcoma virus. The company was founded by Luc Boblet and Marc Eloit on September 14, 2010 and is headquartered in Paris, France. | Health Technology |
